Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

. This study seeks to test the performance of the SeravueTM (LC-SPIK) device alone or in combination with ultrasound as a tool for HCC surveillance in diverse patient populations and clinical settings.